We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.19%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$7.75B
AUM Growth
+$669M
Cap. Flow
+$700M
Cap. Flow %
9.03%
Top 10 Hldgs %
12.73%
Holding
960
New
464
Increased
83
Reduced
134
Closed
249

Top Buys

Rank Stock Value
1
APPH
AppHarvest, Inc. Common Stock
APPH
+$133M
2
ARVL
Arrival Ordinary Shares
ARVL
+$116M
3
PLAN
Anaplan, Inc.
PLAN
+$108M
4
CRM icon
Salesforce
CRM
+$102M
5
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$82.5M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$104M
2
JBL icon
Jabil
JBL
+$77.8M
3
VRT icon
Vertiv
VRT
+$73.3M
4
DOX icon
Amdocs
DOX
+$67.5M
5
PANW icon
Palo Alto Networks
PANW
+$59.9M

Sector Composition

Rank Sector Weight
1 Technology 20.3%
2 Healthcare 13.91%
3 Industrials 13.47%
4 Financials 11.46%
5 Consumer Discretionary 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAND
951
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-89,286
Closed -$1.33M
RPLA
952
DELISTED
Replay Acquisition Corp. Ordinary Shares
RPLA
– –
-26,332
Closed -$274K
NSCO.WS
953
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
– –
-479,592
Closed -$445K
OXFD
954
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-1,341,518
Closed -$23.4M
FSDC
955
DELISTED
FS Development Corp. Class A Common Stock
FSDC
– –
-846,045
Closed -$9.31M
PRVL
956
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
– –
-595,553
Closed -$13.7M
CMAX
957
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
– –
-21,693
Closed -$10.2M
LJPC
958
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-536,847
Closed -$2.08M
PLLL
959
DELISTED
Piedmont Lithium Limited American Depositary Receipts
PLLL
– –
-600,000
Closed -$15.9M
35 36 37 38
39

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2021 Portfolio in Review

As of Q1 2021, Alyeska Investment Group held 960 positions worth $7.75B, up 9.4% from $7.08B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $700M of net new capital in Q1 2021, opening 464 new positions and adding to 83 existing holdings. Its largest new stake was Arrival Ordinary Shares: 118,000 shares worth $83.1M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Microsoft, an estimated $104M trimmed.

  • Alyeska Investment Group's largest Q1 2021 buy was Arrival Ordinary Shares: 118,000 shares worth $83.1M.
  • Alyeska Investment Group added most to AppHarvest, Inc. Common Stock in Q1 2021, an estimated $133M increase.
  • Alyeska Investment Group's biggest Q1 2021 reduction was Microsoft, cutting an estimated $104M.
  • Alyeska Investment Group fully exited Jabil in Q1 2021, selling an estimated $77.8M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $7.75B portfolio in Q1 2021.
  • Alyeska Investment Group opened 464 new positions and closed 249 in Q1 2021.
  • Alyeska Investment Group's portfolio value rose 9.4% quarter-over-quarter to $7.75B.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.